Terms: = Lymphoma AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR AND Prognosis
43 results:
1. Enhancing information on stage at diagnosis for childhood cancer in Africa.
Liu B; Abraham N; Chitsike I; Sylvie CGL; Kambugu J; Stévy NMA; Pondy AHO; Renner L; Parkin DM
Pediatr Blood Cancer; 2023 Oct; 70(10):e30555. PubMed ID: 37432023
[TBL] [Abstract] [Full Text] [Related]
2. Analysis of Cancer Research Projects in Sub-Saharan Africa: A Quantitative Perspective on Unmet Needs and Opportunities.
Davies L; Milner DA; Shulman LN; Kyokunda L; Bedada A; Vuylsteke P; Masalu N; Jackson P; Jennings N; Odunlami A; Mtshali P; Dugan U
JCO Glob Oncol; 2023 Jun; 9():e2200203. PubMed ID: 37290022
[TBL] [Abstract] [Full Text] [Related]
3. Significance of ypTNM stage in determining the prognosis and therapy after surgery for locally advanced rectal cancer.
Chen Y; Sun J; Dong X; Sun D; Qu Y
World J Surg Oncol; 2023 Jun; 21(1):174. PubMed ID: 37287039
[TBL] [Abstract] [Full Text] [Related]
4. An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal lymphomas.
Venturutti L; Rivas MA; Pelzer BW; Flümann R; Hansen J; Karagiannidis I; Xia M; McNally DR; Isshiki Y; Lytle A; Teater M; Chin CR; Meydan C; Knittel G; Ricker E; Mason CE; Ye X; Pan-Hammarström Q; Steidl C; Scott DW; Reinhardt HC; Pernis AB; Béguelin W; Melnick AM
Cancer Discov; 2023 Jan; 13(1):216-243. PubMed ID: 36264161
[TBL] [Abstract] [Full Text] [Related]
5. Use of ifosfamide, carboplatin and etoposide in combination with brentuximab vedotin or romidepsin based on CD30 positivity in relapsed/refractory peripheral T-cell lymphoma.
Gentille C; Sarfraz H; Joshi J; Randhawa J; Shah S; Pingali SR
Cancer Rep (Hoboken); 2022 Jul; 5(7):e1581. PubMed ID: 35263030
[TBL] [Abstract] [Full Text] [Related]
6. Association Between Minor Salivary Gland Biopsy During Sjӧgren's Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis.
Berardicurti O; Ruscitti P; Di Benedetto P; D'Andrea S; Navarini L; Marino A; Cipriani P; Giacomelli R
Front Immunol; 2021; 12():686457. PubMed ID: 34177936
[TBL] [Abstract] [Full Text] [Related]
7. [Semiquantitative parameters of
Liao XH; Wang RF; Liu M; Chen XQ; Xiong Y; Nong L; Yin L; Zhang BY; DU YJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 53(2):246-254. PubMed ID: 33879893
[TBL] [Abstract] [Full Text] [Related]
8. [Application of Antinuclear Antibody and Antinuclear Antibody Spectrum in lymphoma Treatment].
Wang ME; Fan CM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):861-865. PubMed ID: 32552948
[TBL] [Abstract] [Full Text] [Related]
9. Development and validation of an
Wang H; Zhao S; Li L; Tian R
Eur Radiol; 2020 Oct; 30(10):5578-5587. PubMed ID: 32435928
[TBL] [Abstract] [Full Text] [Related]
10. Prevalence and effects of polypharmacy on overall survival in acute myeloid leukemia.
Dhakal P; Lyden E; Muir KE; Al-Kadhimi ZS; Koll T; Maness LJ; Gundabolu K; Bhatt VR
Leuk Lymphoma; 2020 Jul; 61(7):1702-1708. PubMed ID: 32157936
[TBL] [Abstract] [Full Text] [Related]
11. Anti-Ro52 and/or anti-Ro60 immune reactivity: autoantibody and disease associations.
Zampeli E; Mavrommati M; Moutsopoulos HM; Skopouli FN
Clin Exp Rheumatol; 2020; 38 Suppl 126(4):134-141. PubMed ID: 32083547
[TBL] [Abstract] [Full Text] [Related]
12. High pretreatment plasma Epstein-Barr virus (EBV) DNA level is a poor prognostic marker in HIV-associated, EBV-negative diffuse large B-cell lymphoma in Malawi.
Montgomery ND; Randall C; Painschab M; Seguin R; Kaimila B; Kasonkanji E; Zuze T; Krysiak R; Sanders MK; Elliott A; Miller MB; Kampani C; Chimzimu F; Mulenga M; Damania B; Tomoka T; Fedoriw Y; Dittmer DP; Gopal S
Cancer Med; 2020 Jan; 9(2):552-561. PubMed ID: 31782984
[TBL] [Abstract] [Full Text] [Related]
13. The prognostic value of tumour-associated macrophages in Non-Hodgkin's lymphoma: A systematic review and meta-analysis.
Xu X; Li Z; Liu J; Zhu F; Wang Z; Wang J; Zhang J; Wang H; Zhai Z
Scand J Immunol; 2020 Jan; 91(1):e12814. PubMed ID: 31419843
[TBL] [Abstract] [Full Text] [Related]
14. Mature outcomes and prognostic indices in diffuse large B-cell lymphoma in Malawi: a prospective cohort.
Painschab MS; Kasonkanji E; Zuze T; Kaimila B; Tomoka T; Nyasosela R; Nyirenda R; Dhungel BM; Mulenga M; Chikasema M; Tewete B; Mtangwanika A; Chiyoyola S; Mhango W; Chimzimu F; Kampani C; Krysiak R; Shea TC; Montgomery ND; Fedoriw Y; Gopal S
Br J Haematol; 2019 Feb; 184(3):364-372. PubMed ID: 30450671
[TBL] [Abstract] [Full Text] [Related]
15. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma].
Ding CY; Guo Z; Sun J; Yang WP; Li TR
Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):528-533. PubMed ID: 30060362
[No Abstract] [Full Text] [Related]
16. Molecular Markers and prognosis of Myelofibrosis in the Genomic Era: A Meta-analysis.
Lee YC; Hsieh CC; Lee YL; Li CY
Clin Lymphoma Myeloma Leuk; 2018 Sep; 18(9):558-568. PubMed ID: 29970342
[TBL] [Abstract] [Full Text] [Related]
17. Diagnosis and classification of hematologic malignancies on the basis of genetics.
Taylor J; Xiao W; Abdel-Wahab O
Blood; 2017 Jul; 130(4):410-423. PubMed ID: 28600336
[TBL] [Abstract] [Full Text] [Related]
18. Identification of prognostic risk factors of acute lymphoblastic leukemia based on mRNA expression profiling.
Li C; Kuang L; Zhu B; Chen J; Wang X; Huang X
Neoplasma; 2017; 64(4):494-501. PubMed ID: 28485154
[TBL] [Abstract] [Full Text] [Related]
19. Plasma Epstein-Barr virus DNA for pediatric Burkitt lymphoma diagnosis, prognosis and response assessment in Malawi.
Westmoreland KD; Montgomery ND; Stanley CC; El-Mallawany NK; Wasswa P; van der Gronde T; Mtete I; Butia M; Itimu S; Chasela M; Mtunda M; Kampani C; Liomba NG; Tomoka T; Dhungel BM; Sanders MK; Krysiak R; Kazembe P; Dittmer DP; Fedoriw Y; Gopal S
Int J Cancer; 2017 Jun; 140(11):2509-2516. PubMed ID: 28268254
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic value of whole-body SUVmax of nodal and extra-nodal lesions detected by 18F-FDG PET/CT in extra-nodal NK/T-cell lymphoma.
Liang JH; Ding CY; Gale RP; Wang L; Xu J; Qu XY; Fan L; Li TL; Li JY; Xu W
Oncotarget; 2017 Jan; 8(1):1737-1743. PubMed ID: 27974685
[TBL] [Abstract] [Full Text] [Related]
[Next]
